⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Global Nuclear Medicine, PET, and Radiopharmaceuticals Market Size, Trends and Forecast 2025-2036 | Theranostics, Digital PET, and AI Unlock High-Growth Opportunities
globenewswire.com
GEHC
LLY
BMY
AZN
CBZ
BWXT
Edge AI Software Market Size, Share, Trends, and Global Forecast to 2032 | Generative AI Moves to the Device, Sending Edge AI Software Toward $120 Billion
globenewswire.com
MSFT
GOOG
IBM
DELL
INTC
HON
SI
SCL
AN
INFY
ACN
CG
NVDA
AMD
QCOM
NET
SMCI
MRVL
NXPI
ON
ADBE
CRM
ORCL
PANW
SNOW
DDOG
PLTR
GOOGL
AMZN
DE
CAT
GE
BA
TSLA
GM
F
MU
AMAT
LRCX
KLAC
ASML
TXN
ADI
MCHP
STX
WDC
NTAP
CTAS
RSG
WM
GWW
FAST
AEP
NEE
XEL
PCG
ED
VRSN
NOW
ADSK
CDNS
SNPS
MRNA
PFE
JNJ
BMY
GILD
REGN
BIIB
VRTX
AMGN
LLY
ABBV
V
MA
AXP
JPM
BAC
WFC
GS
MS
SCHW
PYPL
COIN
MPWR
AEHR
ENPH
SEDG
PLUG
FCEL
BE
NRG
EXC
SO
D
CMS
ETR
TECK
NEM
AU
RIO
BHP
VALE
STLD
NUE
CF
MOS
DD
DOW
ECL
AVB
EQIX
CCI
AMT
SBAC
PLD
AXL
MATH
Nutraceutical Ingredients Market Forecasts Growth from $108.33 Billion (2026) to $161.53 Billion by 2031, Profiling Cargill, ADM, dsm-firmenich, Kerry & 21 Other Key Players
globenewswire.com
ADM
IFF
BG
LIN
MKC
NOV
PG
SCL
SYK
T
TGT
TSN
WMT
XOM
ZTS
BCH
KDP
GIS
CPB
HRL
KHC
SJM
CL
PEP
KO
COST
CVX
BA
CAT
DIS
GE
GS
JNJ
JPM
MCD
MRK
MSFT
PFE
PM
RTX
SBUX
SPG
UNH
UPS
VZ
WFC
AMZN
GOOGL
AAPL
NVDA
TSLA
META
NFLX
CMCSA
INTC
AMD
QCOM
AMGN
GILD
BMY
ABBV
LLY
NVO
AZN
BNTX
MRNA
CRSP
REGN
VRTX
BIIB
ALKS
BMRN
EXAS
ILMN
MELI
PYPL
COIN
MARA
ETSY
JD
BABA
NTES
PDD
BIDU
EDU
TAL
BEKE
NIO
LI
XPEV
RIVN
LCID
PLTR
SNOW
DDOG
CRWD
PANW
ZS
FTNT
NOW
CRM
ADSK
CSCO
IBM
ORCL
SAP
ACN
MU
WDC
EXPE
BKNG
MAR
HLT
RH
KOS
INGR
CARG
Lilly Endowment Awards $10 Million Capacity-Building Grant to Homes For Our Troops to Advance Mission of Building Homes and Rebuilding Lives
globenewswire.com
LLY
The Consortium for Top-Down Proteomics is now The Proteoform Alliance, with the Expanded Mission to Unlock the Full Potential of Proteoform Biology
globenewswire.com
TMO
BRKR
LLY
PFE
A
QSI
Cell Culture Market - Global Size, Share, Trends, and Forecast 2026-2032 | USD 80.23 Billion Opportunity Fueled by Biologics, Cell Therapies, AI, and Single-Use Systems
globenewswire.com
BDX
BIIB
BKR
CHTR
CL
CMCSA
COR
CSCO
DHR
DIS
EMR
GOOG
IBM
INTC
JNJ
LLY
META
MRK
MSFT
MU
NFLX
NVDA
ORCL
PAYX
PEP
PFE
QCOM
ROKU
SMCI
SNOW
TCOM
TEAM
TECK
TMUS
TSLA
TXN
VRTX
WDC
XOM
AMD
AMZN
AVTR
BIO
BMY
CAT
CHKP
CTAS
CTSH
DELL
DOV
EA
EBAY
EXC
FAST
FDX
FIS
FISV
GILD
GOOGL
HON
HSIC
IDXX
ILMN
INTU
ISRG
JD
KDP
KHC
KLAC
LRCX
LULU
MAR
MCHP
MDLZ
MELI
MNST
MO
MRVL
NTAP
NXPI
ORLY
PCAR
PDD
PGR
PHG
PLTR
PNW
PPG
PTON
PRGS
PSA
RCL
REGN
ROST
RYAAY
SBUX
SIRI
SNPS
SO
SWKS
SYK
T
TEL
TER
TGT
TMO
ULTA
UPS
VRSK
VTR
WEC
WFC
WMB
XRAY
ZBRA
ZION
ZTS
United States Personalized Medicine Market - Genomic Trends, Size, Share, and Forecast 2026-2034 | AI, NGS, and Targeted Therapies Propel Growth to US$327.97 Billion
globenewswire.com
ABT
GEHC
ILMN
QGEN
LLY
TAK
ABBV
Denmark Pharmaceutical Market - Size, Share, Drug Development, Competitive Analysis, and Forecast 2026-2034 | Biologics and Personalized Medicine Drive Growth to US$5.38 Billion
globenewswire.com
NVO
UCB
LLY
Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis
prnewswire.com
LLY
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
prnewswire.com
LLY